Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Modular gene enhancers may be suitable target in treatment of blood cancer

Modular gene enhancers may be suitable target in treatment of blood cancer

FDA grants approval for first drug to treat inherited breast cancer

FDA grants approval for first drug to treat inherited breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Leukemia patients currently ineligible for targeted therapy may benefit from new drugs

Leukemia patients currently ineligible for targeted therapy may benefit from new drugs

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Clinical study uses genetic testing to match AML patients with new therapies

Clinical study uses genetic testing to match AML patients with new therapies

UC San Diego researchers receive nearly $8 million grant for new stem cell-based AML treatments

UC San Diego researchers receive nearly $8 million grant for new stem cell-based AML treatments

Study finds unexpected new drug target for acute myeloid leukemia

Study finds unexpected new drug target for acute myeloid leukemia

High levels of natural immune suppressor in leukemia patients linked to poor survival

High levels of natural immune suppressor in leukemia patients linked to poor survival

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Powering up fat cells could help acute myeloid leukemia patients

Powering up fat cells could help acute myeloid leukemia patients

Newly discovered compound causes cancer cell death, whilst sparing healthy cells

Newly discovered compound causes cancer cell death, whilst sparing healthy cells

New treatment approach makes cancer cells commit suicide while sparing healthy cells

New treatment approach makes cancer cells commit suicide while sparing healthy cells

New research uncovers how blood cancer 'steals' parts of bone marrow cells to thrive

New research uncovers how blood cancer 'steals' parts of bone marrow cells to thrive

Trial identifies genetic fault that affects treatment response in leukemia patients

Trial identifies genetic fault that affects treatment response in leukemia patients

Modified blood thinner may be first promising method to prevent repercussions after TBI

Modified blood thinner may be first promising method to prevent repercussions after TBI

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML